BSA‐AIE Nanoparticles with Boosted ROS Generation for Immunogenic Cell Death Immunotherapy of Multiple Myeloma

Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions

(2022) Emma Verheye et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Harnessing the Immune System Against Multiple Myeloma: Challenges and Opportunities

(2021) Leona Yamamoto et al.   Frontiers in Oncology

Bone marrow‐derived mesenchymal stem cells inhibit CD8 + T cell immune responses via PD‐1/PD‐L1 pathway in multiple myeloma

(2021) Z. Liu et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Hypochlorous acid selectively promotes toxicity and the expression of danger signals in human abdominal cancer cells

(2021) Eric Freund et al.   ONCOLOGY REPORTS

Predictive Role of Immune Profiling for Survival of Multiple Myeloma Patients

(2021) Liu Zhaoyun et al.   Frontiers in Immunology

Immunotherapy of multiple myeloma

(2020) Simone A. Minnie et al.   JOURNAL OF CLINICAL INVESTIGATION

Endoplasmic reticulum targeted AIE bioprobe as a highly efficient inducer of immunogenic cell death

(2020) Jun Li et al.   Science China-Chemistry

Immune-based therapies in the management of multiple myeloma

(2020) Saurabh Zanwar et al.   Blood Cancer Journal

Targeting immunogenic cell death in cancer

(2020) Asma Ahmed et al.   Molecular Oncology

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

(2019) Jérôme Galon et al.   NATURE REVIEWS DRUG DISCOVERY

Semiconducting Perylene Diimide Nanostructure: Multifunctional Phototheranostic Nanoplatform

(2019) Zhen Yang et al.   ACCOUNTS OF CHEMICAL RESEARCH

Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice

(2019) Wenwen Yue et al.   Nature Communications

Targeted APC Activation in Cancer Immunotherapy to Enhance the Abscopal Effect

(2019) Nathan Suek et al.   Frontiers in Immunology

Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma

(2019) Siler H. Panowski et al.   MOLECULAR CANCER THERAPEUTICS

Massively Evoking Immunogenic Cell Death by Focused Mitochondrial Oxidative Stress using an AIE Luminogen with a Twisted Molecular Structure

(2019) Chao Chen et al.   ADVANCED MATERIALS

TIGIT immune checkpoint blockade restores CD8+T cell immunity against multiple myeloma

(2018) Camille Guillerey et al.   BLOOD

Clinical Pharmacokinetics and Pharmacodynamics of Bortezomib

(2018) Carlyn Rose C. Tan et al.   CLINICAL PHARMACOKINETICS

Global Burden of Multiple Myeloma

(2018) Andrew J. Cowan et al.   JAMA Oncology

In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment

(2018) Qian Chen et al.   Nature Nanotechnology

Conjugation of haematopoietic stem cells and platelets decorated with anti-PD-1 antibodies augments anti-leukaemia efficacy

(2018) Quanyin Hu et al.   Nature Biomedical Engineering

Is immunotherapy here to stay in multiple myeloma?

(2017) Paula Rodríguez-Otero et al.   HAEMATOLOGICA

A high quantum yield molecule-protein complex fluorophore for near-infrared II imaging

(2017) Alexander L. Antaris et al.   Nature Communications

Is immunotherapy here to stay in multiple myeloma?

(2017) Paula Rodríguez-Otero et al.   HAEMATOLOGICA

The Role of Dendritic Cell Maturation in the Induction of Insulin-Dependent Diabetes Mellitus

(2017) Jacques C. Mbongue et al.   Frontiers in Immunology

Multiple myeloma

(2017) Shaji K. Kumar et al.   Nature Reviews Disease Primers

Multiple myeloma in Niger Delta, Nigeria: complications and the outcome of palliative interventions

(2017) Ogbonna Collins Nwabuko et al.   Cancer Management and Research

CD57 in human natural killer cells and T-lymphocytes

(2016) Hassen Kared et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell–driven rejection of high-grade glioma

(2016) Abhishek D. Garg et al.   Science Translational Medicine

Analysis of nanoparticle delivery to tumours

(2016) Stefan Wilhelm et al.   Nature Reviews Materials

Nanoparticles in Photodynamic Therapy

(2015) Sasidharan Swarnalatha Lucky et al.   CHEMICAL REVIEWS

Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma

(2015) Henk M. Lokhorst et al.   NEW ENGLAND JOURNAL OF MEDICINE

The future of immune checkpoint therapy

(2015) P. Sharma et al.   SCIENCE

Lymphocyte Subset Recovery and Outcome after Autologous Hematopoietic Stem Cell Transplantation for Plasma Cell Myeloma

(2014) Jessica Rueff et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

(2013) S K Kumar et al.   LEUKEMIA

Coinhibitory molecule PD-1 as a potential target for the immunotherapy of multiple myeloma

(2013) D Atanackovic et al.   LEUKEMIA

Immunogenic Cell Death in Cancer Therapy

(2012) Guido Kroemer et al.   Annual Review of Immunology

Pharmacokinetic, Pharmacodynamic and Covariate Analysis of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients with Relapsed Multiple Myeloma

(2012) Philippe Moreau et al.   CLINICAL PHARMACOKINETICS

Enlightening the impact of immunogenic cell death in photodynamic cancer therapy

(2012) Lorenzo Galluzzi et al.   EMBO JOURNAL

Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin

(2011) Abhishek D. Garg et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Leukocyte composition of human breast cancer

(2011) B. Ruffell et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma

(2010) A. P. Rapoport et al.   BLOOD

Prognostically significant cytotoxic T cell clones are stimulated after thalidomide therapy in patients with multiple myeloma

(2010) Ross D. Brown et al.   LEUKEMIA & LYMPHOMA

PD-1 and Its Ligands in Tolerance and Immunity

(2008) Mary E. Keir et al.   Annual Review of Immunology